EMBAR

Author:
Rajaa Ali Habeeb
Department of Pathological Analyses, College of Science, University of Al-Qadisiyah, Al-Qadisiyah, Iraq

DOI: doi.org/10.58924/rjmp.v4.iss4.p1

Published Date: 21-Aug, 2025

Keywords: Gram-negative bacteria, PCR, IL-10, ELISA, NCBI, Iraq

Abstract:
Abstract Background:Bordetellabronchiseptica isa Gram-negative bacterium which known to cause respiratory disease in pet animals, and can colonize the human respiratory tract. Recently, B.bronchiseptica infections arerestricted to humans and increasing worldwide. Aim: Molecular indication of B.bronchiseptica in respiratory-diseased patientswith sequencing and phylogenetically analyzing close-relationship betweenstudy and global isolates, as well as measuring levels of interleukin-10 in study individuals. Materials and methods: An overall 150 patients with various clinical signs were subjected to collection of nasal swabs for molecular testing by the conventional PCR assay.Then, some positive B.bronchisepticaisolates were sequenced and analysedphylogeneticallyby the MEGA-11 software to identify its identity to the global NCBI-GenBankB.bronchiseptica isolates / strains.Also, samples of venous blood were obtained from the study population as well as from 30 healthy individuals to estimate serologically the levels of IL-10. Results: This study revealed that 10.99% of respiratory-diseased patients were positively infected with B.bronchiseptica. Phylogenetically,analyzing of study isolatesdetected the presence of similarity and mutations / changes at ranges of 98.14-99.91% and 0.0004-0.002%, respectively. Phylgenetic tree and multiple sequence alignment demonstrated that identity of study B.bronchiseptica isolates was to Mexican B.bronchiseptica strain (GenBank ID: FJ867619.1). The levels of IL-10 were elevated significantly in respiratory-diseased patients when compared to healthy, but not between the positively and negatively B.bronchiseptica infected patients. Conclusion: This study implicates molecularly,for the first time in Iraq, B.bronchiseptica in respiratory-diseased patients,close-relationship between the study and global isolates throughout phylogenetic analysis, and the level of IL-10 in respiratory-diseasedand the healthy population. Received: 10-08-2025 Revised: 12-08-2025 Accepted: 17-08-2025 Published: 21-08-2025 Copyright:© 2025 by the authors. Submitted for possible open access publication under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Furthermore molecular studies are greatly needed to insight the role of B.bronchiseptica in other human infections.

References:

1. Abellan-Schneyder, I., Matchado, M.S., Reitmeier, S., Sommer, A., Sewald, Z., Baumbach, J., and Neuhaus, K. (2021). Primer, pipelines, parameters: issues in 16S rRNA gene sequencing. Msphere, 6(1), 10-1128.

2. Aktay-Cetin, Ö.,Pullamsetti, S. S., Herold, S., and Savai, R. (2025). Lung tumor immunity: redirecting macrophages through infection-induced inflammation. Trends in Immunology.

3. Al-Gharban, H.A.A.J. (2017). Seroepidemiological detection and culture utilization for diagnosis of carrier horses and donkeys with strangles.Journal of Education College Wasit University, 1(28), 649-660.

4. Barreto, D.P., Conrad, R., Klose, M., Claus, P., and Enrich-Prast, A. (2014). Distance-decay and taxa-area relationships for bacteria, archaea and methanogenicarchaea in a tropical lake sediment. Plos one, 9(10), e110128.

5. Belcher, T., Dubois, V., Rivera-Millot, A., Locht, C., and Jacob-Dubuisson, F. (2021).Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host.Virulence, 12(1), 2608-2632.

6. Bose, N., and Moore, S. D. (2023). Variable region sequences influence 16S rRNA performance. Microbiology Spectrum, 11(3), e01252-23.

7. Brown, M. A. (2022). The epithelial cell in host-pathogen interactions in airways disease (Doctoral dissertation, University of Oxford).

8. Calderaro, A., Buttrini, M., Farina, B., Montecchini, S., De Conto, F., and Chezzi, C. (2022). Respiratory tract infections and laboratory diagnostic methods: a review with a focus on syndromic panel-based assays. Microorganisms, 10(9), 1856.

9. Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., and Albini, A. (2023). The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Frontiers in immunology, 14, 1161067.

10. Caulfield, A. D., Callender, M., and Harvill, E. T. (2023). Generating enhanced mucosal immunity against Bordetella pertussis: current challenges and new directions. Frontiers in Immunology, 14, 1126107.

11. de AraújoMorais, A. H., de Souza Aquino, J., da Silva-Maia, J. K., de Lima Vale, S. H., Maciel, B. L. L., and Passos, T. S. (2021). Nutritional status, diet and viral respiratory infections: perspectives for severe acute respiratory syndrome coronavirus 2. British Journal of Nutrition, 125(8), 851-862

12. Dworkin, M. S., Sullivan, P. S., Buskin, S. E., Harrington, R. D., Olliffe, J., MacArthur, R. D., and Lopez, C. E. (1999). Bordetellabronchiseptica infection in human immunodeficiency virus-infected patients.Clinical infectious diseases, 28(5), 1095-1099.

13. Einarsson, G. G., and Boutin, S. (2019). Techniques: culture, identification and 16S rRNA gene sequencing. The Lung Microbiome (ERS Monography), 18-34.

14. García-de-la-Fuente, C., Guzmán, L., Cano, M. E., Agüero, J., Sanjuán, C., Rodríguez, C., and Martínez-Martínez, L. (2015). Microbiological and clinical aspects of respiratory infections associated with Bordetellabronchiseptica. Diagnostic microbiology and infectious disease, 82(1), 20-25.

15. Gueirard, P., Weber, C., Le Coustumier, A., and Guiso, N. (1995). Human Bordetellabronchiseptica infection related to contact with infected animals: persistence of bacteria in host. Journal of clinical microbiology, 33(8), 2002-2006.

16. Gulati, K., Guhathakurta, S., Joshi, J., Rai, N., and Ray, A. J. M. I. (2016). Cytokines and their role in health and disease: a brief overview. MojImmunol, 4(2), 00121.

17. Harvanová, G., Duranková, S., and Bernasovská, J. (2023).The role of cytokines and chemokines in the inflammatory response.AlergologiaPolska-Polish Journal of Allergology, 10(3), 210-219.

18. Huaux, F. (2021).Interpreting immunoregulation in lung fibrosis: a new branch of the immune model.Frontiers in Immunology, 12, 690375.

19. Ibraheim, H. K., Madhi, K. S., Baqer, G. K., and Gharban, H. A. (2023). Effectiveness of raw bacteriocin produced from lactic acid bacteria on biofilm of methicillin-resistant Staphylococcus aureus. Veterinary World, 16(3), 491.

20. Jasim, M. J., and Radhy, A. M. (2025).Clinical and molecular study of upper respiratory tract infections of cats caused by Bordetellabronchiseptica in cats at Baghdad city.Cuestiones de Fisioterapia, 54(3), 563-580.

21. Junainah, E. M., Abd-El-Rahman, A. H., Alamin, A. A., Hassan, K. E., Elesawy, B. H., Elrashidy, A. H., and Taha, S. A. (2025). Immunopathology and therapeutic strategies for long COVID: mechanisms, manifestations, and clinical implications. AIDS reviews, 27(1).

22. Kadhim, H. M., Al-Galebi, A. A. S., Al-Hassani, M. K., and Gharban, H. A. (2025).Molecular and serological incidences of Bordetellabronchiseptica in pet dogs with urinary infections.Open Veterinary Journal, 15(3), 1397.

23. Kadlec, K., and Schwarz, S. (2018). Antimicrobial resistance in Bordetellabronchiseptica.Microbiology spectrum, 6(4), 10-1128.

24. Kany, S., Vollrath, J. T., and Relja, B. (2019).Cytokines in inflammatory disease.International journal of molecular sciences, 20(23), 6008.

25. Kumar, R., Ng, S., and Engwerda, C. (2019). The role of IL-10 in malaria: a double edged sword. Frontiers in immunology, 10, 229.

26. Macpherson, M. L., Pinckney, R., Sylvester, W., Bidaisee, S., and Macpherson, C. N. (2022). Man’s best friend and our shared infectious diseases. CABI Reviews, (2022).

27. Malik, M., Kumar, N., and Dixit, C. P. (2025).Pathophysiology of Respiratory Disorders.In Fundamentals of Veterinary Pathophysiology (pp. 140-151).CRC Press.

28. Mattoo, S., and Cherry, J. D. (2005).Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Clinical microbiology reviews, 18(2), 326-382.

29. Miguelena Chamorro, B., De Luca, K., Swaminathan, G., Longet, S., Mundt, E., and Paul, S. (2023). Bordetellabronchiseptica and Bordetella pertussis: similarities and differences in infection, immuno-modulation, and vaccine considerations. Clinical Microbiology Reviews, 36(3), e00164-22.

30. Mohammad, H.A., Gharban, H.A.G., and Ajaj, E.A. (2025).Molecular and phylogenetic analysis of Bordetellabronchisepteca in respiratory-diseased pet dogs.Iraqi Journal of Veterinary Sciences, 39(4), 1-14.

31. Nazir, R., Rehman, S., Nisa, M., and ali Baba, U. (2019). Exploring bacterial diversity: from cell to sequence. In Freshwater Microbiology (pp. 263-306).Academic Press.

32. Nie, J., Zhou, L., Tian, W., Liu, X., Yang, L., Yang, X., and Wei, J. (2025). Deep insight into cytokine storm: from pathogenesis to treatment. Signal Transduction and Targeted Therapy, 10(1), 1-38.

33. Nieves, D. J., and Heininger, U. (2016).Bordetella pertussis.Emerging Infections 10, 311-339.

34. Nunes Ramos, J., Veloso da Costa, L., Viana Vieira, V., and Lima Brandão, M. L. (2025). Challenges in the Identification of Environmental Bacterial Isolates from a Pharmaceutical Industry Facility by 16S rRNA Gene Sequences.DNA, 5(3), 33.

35. Parrish, K. M., and Gestal, M. C. (2024).Eosinophils as drivers of bacterial immunomodulation and persistence.Infection and Immunity, 92(9), e00175-24.

36. Rose, K. T., Rajesh, J. B., Marwein, S. C., Kar, P., Behera, S. K., Bayan, H., and Prasad, H. (2025).Significance of Bordetellabronchiseptica in Respiratory Tract Infections of Canines.International Journal of Bio-Resource and Stress Management, 16(1).

37. Saxton, R. A., Glassman, C. R., and Garcia, K. C. (2023).Emerging principles of cytokine pharmacology and therapeutics.Nature Reviews Drug Discovery, 22(1), 21-37.

38. Steen, E. H., Wang, X., Balaji, S., Butte, M. J., Bollyky, P. L., and Keswani, S. G. (2020).The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis.Advances in wound care, 9(4), 184-198.

39. Wang, X., Wong, K., Ouyang, W., and Rutz, S. (2019).Targeting IL-10 family cytokines for the treatment of human diseases.Cold Spring Harbor perspectives in biology, 11(2), a028548.

40. Weinroth, M. D., Belk, A. D., Dean, C., Noyes, N., Dittoe, D. K., RothrockJr, M. J., and Wells, J. E. (2022). Considerations and best practices in animal science 16S ribosomal RNA gene sequencing microbiome studies.Journal of animal science, 100(2), skab346.

41. Woods, P., Ordemann, K., Stanecki, C., Brown, J., and Uzodi, A. (2020).Bordetellabronchiseptica pneumonia in an adolescent: case report and review of the pediatric literature. Clinical Pediatrics, 59(3), 322-328.

42. Woolfrey, B. F., and Moody, J. A. (1991). Human infections associated with Bordetellabronchiseptica. Clinical microbiology reviews, 4(3), 243-255.

43. Yi, L., Fan, H., Yuan, S., Li, R., Wang, H., Quan, Y., and Wang, Y. (2024). Antimicrobial Resistance and Biofilm Formation of Bordetellabronchiseptica in Central China, with Evidence of a Rare Heteroresistance Strain to Gentamicin.Animals, 14(9), 1301.

44. Zafar, M. A., Hernandez, G. E., and Walker, K. A. (2025).Mechanisms of bacterial host-to-host transmission.Microbiology and Molecular Biology Reviews, e00259-24.